Gastric Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2006; 12(11): 1694-1698
Published online Mar 21, 2006. doi: 10.3748/wjg.v12.i11.1694
Figure 1
Figure 1 Cell growth inhibition in BGC-823 cells after tachyplesin, n-sodium butyrate and their combination treatment (×104 cells/mL).
Figure 2
Figure 2 Influence of tachyplesin, n-sodium butyrate and their combination on mitotic index (A) and cell cycle (B) of BGC-823 cells.
Figure 3
Figure 3 Expression of c-erbB-2 (A-D), c-myc (E-H), p53 (I-L), and p16 (M-R) in BGC-823 cells, tachyplesin-treated cells, n-sodium butyrate-treated cells, and tachyplesin + n-sodium butyrate-treated cells. ×536.